These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31409888)

  • 1. Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo.
    Krawczyk E; Hong SH; Galli S; Trinh E; Wietlisbach L; Misiukiewicz SF; Tilan JU; Chen YS; Schlegel R; Kitlinska J
    Lab Invest; 2020 Jan; 100(1):38-51. PubMed ID: 31409888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.
    Jin W; Zhang Y; Zhao Z; Gao M
    Theranostics; 2024; 14(9):3439-3469. PubMed ID: 38948053
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.
    Lu J; Guan S; Zhao Y; Yu Y; Woodfield SE; Zhang H; Yang KL; Bieerkehazhi S; Qi L; Li X; Gu J; Xu X; Jin J; Muscal JA; Yang T; Xu GT; Yang J
    Cancer Lett; 2017 Aug; 400():61-68. PubMed ID: 28455243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the developmental origin of neuroblastoma: an overview.
    Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
    J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
    Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
    J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
    Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
    Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of neuroblastoma cell lineage phenotypes and
    Campos Cogo S; Gradowski Farias da Costa do Nascimento T; de Almeida Brehm Pinhatti F; de França Junior N; Santos Rodrigues B; Cavalli LR; Elifio-Esposito S
    Exp Biol Med (Maywood); 2020 Dec; 245(18):1637-1647. PubMed ID: 32787463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.
    Terrile M; Bryan K; Vaughan L; Hallsworth A; Webber H; Chesler L; Stallings RL
    PLoS One; 2011; 6(12):e28356. PubMed ID: 22164278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
    Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA N
    Cheng J; Xu L; Deng L; Xue L; Meng Q; Wei F; Wang J
    Sci Rep; 2020 Aug; 10(1):13624. PubMed ID: 32788584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.
    Sainero-Alcolado L; Mushtaq M; Liaño-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Pérez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
    J Exp Clin Cancer Res; 2022 Jul; 41(1):226. PubMed ID: 35850708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis.
    Dorneburg C; Fischer M; Barth TFE; Mueller-Klieser W; Hero B; Gecht J; Carter DR; de Preter K; Mayer B; Christner L; Speleman F; Marshall GM; Debatin KM; Beltinger C
    Clin Cancer Res; 2018 Nov; 24(22):5772-5783. PubMed ID: 29925504
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma.
    Kimura K; Kishida T; Wakao J; Tanaka T; Higashi M; Fumino S; Aoi S; Furukawa T; Mazda O; Tajiri T
    J Pediatr Surg; 2016 Dec; 51(12):2068-2073. PubMed ID: 27686479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.
    Carlson LM; Rasmuson A; Idborg H; Segerström L; Jakobsson PJ; Sveinbjörnsson B; Kogner P
    Carcinogenesis; 2013 May; 34(5):1081-8. PubMed ID: 23349014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
    Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.